# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-20-003756
Filing Date
2020-04-09
Accepted
2020-04-09 16:01:55
Documents
8
Period of Report
2020-05-20
Effectiveness Date
2020-04-09

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | def14a.htm | DEF 14A | 1957342
2 | GRAPHIC | def14ag001.jpg | GRAPHIC | 44794
3 | GRAPHIC | def14ag002.jpg | GRAPHIC | 122299
4 | GRAPHIC | def14ag003.jpg | GRAPHIC | 45394
5 | GRAPHIC | def14ag004.jpg | GRAPHIC | 10078
6 | GRAPHIC | def14ag005.jpg | GRAPHIC | 9985
7 | GRAPHIC | def14ag006.gif | GRAPHIC | 118768
8 | GRAPHIC | def14ag007.gif | GRAPHIC | 89353
| Complete submission text file | 0001558370-20-003756.txt |  | 2565903

Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37372 | Film No.: 20784493
SIC: 2834 Pharmaceutical Preparations